# Mechanism of Endoplasmic Reticulum Stress in Cerebral Ischemia

**Authors:** Yu Han, Mei Yuan, Yi-Sha Guo, Xin-Ya Shen, Zhen-Kun Gao, Xia Bi

PMC · DOI: 10.3389/fncel.2021.704334 · Frontiers in Cellular Neuroscience · 2021-08-02

## TL;DR

This paper reviews how endoplasmic reticulum stress contributes to brain damage in strokes and explores its role in cell survival and death.

## Contribution

The paper provides a comprehensive review of recent findings on ER stress mechanisms in cerebral ischemia and their implications for treatment.

## Key findings

- Mild ER stress activates protective mechanisms in ischemic brain cells.
- Chronic ER stress triggers apoptosis through inflammatory and apoptotic pathways.
- Understanding ER stress could lead to new treatments for stroke recovery.

## Abstract

Endoplasmic reticulum (ER) is the main organelle for protein synthesis, trafficking and maintaining intracellular Ca2+ homeostasis. The stress response of ER results from the disruption of ER homeostasis in neurological disorders. Among these disorders, cerebral ischemia is a prevalent reason of death and disability in the world. ER stress stemed from ischemic injury initiates unfolded protein response (UPR) regarded as a protection mechanism. Important, disruption of Ca2+ homeostasis resulted from cytosolic Ca2+ overload and depletion of Ca2+ in the lumen of the ER could be a trigger of ER stress and the misfolded protein synthesis. Brain cells including neurons, glial cells and endothelial cells are involved in the complex pathophysiology of ischemic stroke. This is generally important for protein underfolding, but even more for cytosolic Ca2+ overload. Mild ER stress promotes cells to break away from danger signals and enter the adaptive procedure with the activation of pro-survival mechanism to rescue ischemic injury, while chronic ER stress generally serves as a detrimental role on nerve cells via triggering diverse pro-apoptotic mechanism. What’s more, the determination of some proteins in UPR during cerebral ischemia to cell fate may have two diametrically opposed results which involves in a specialized set of inflammatory and apoptotic signaling pathways. A reasonable understanding and exploration of the underlying molecular mechanism related to ER stress and cerebral ischemia is a prerequisite for a major breakthrough in stroke treatment in the future. This review focuses on recent findings of the ER stress as well as the progress research of mechanism in ischemic stroke prognosis provide a new treatment idea for recovery of cerebral ischemia.

## Linked entities

- **Chemicals:** Ca2+ (PubChem CID 271)
- **Diseases:** cerebral ischemia (MONDO:0002679), ischemic stroke (MONDO:1060198)

## Full-text entities

- **Genes:** Camk2a (calcium/calmodulin-dependent protein kinase II alpha) [NCBI Gene 25400] {aka PK2CDD, PKCCD}, Atf4 (activating transcription factor 4) [NCBI Gene 79255], Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Eif2a (eukaryotic translation initiation factor 2A) [NCBI Gene 502531], Taok3 (TAO kinase 3) [NCBI Gene 304530] {aka JIK}, Casp8 (caspase 8) [NCBI Gene 64044] {aka CASP-8}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, NPY4R (neuropeptide Y receptor Y4) [NCBI Gene 5540] {aka NPY4-R, PP1, PPYR1, Y4}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, ERO1A (endoplasmic reticulum oxidoreductase 1 alpha) [NCBI Gene 30001] {aka ERO1-L, ERO1-L-alpha, ERO1-alpha, ERO1L, ERO1LA, Ero1alpha}, Orai1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 304496] {aka RGD1311873}, Bid (BH3 interacting domain death agonist) [NCBI Gene 64625], Hes1 (hes family bHLH transcription factor 1) [NCBI Gene 29577], Trib3 (tribbles pseudokinase 3) [NCBI Gene 246273] {aka NIPK}, Bcl2l1 (Bcl2-like 1) [NCBI Gene 24888] {aka Bcl-xl, Bcl2l, Bclx, bcl-X}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Casp12 (caspase 12) [NCBI Gene 156117], Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Qrich1 (glutamine-rich 1) [NCBI Gene 301004] {aka RGD1311095}, Csf3 (colony stimulating factor 3) [NCBI Gene 25610] {aka Gcsf}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Ddit3 (DNA-damage inducible transcript 3) [NCBI Gene 29467] {aka CHOP, CHOP-10, Chop10, Gadd153, RM4}, Calr (calreticulin) [NCBI Gene 64202], DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, Xbp1 (X-box binding protein 1) [NCBI Gene 289754] {aka HTF}, CASP4 (caspase 4) [NCBI Gene 837] {aka CASP-4, ICE(rel)II, ICEREL-II, ICH-2, Mih1, Mih1/TX}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, Map3k5 (mitogen-activated protein kinase kinase kinase 5) [NCBI Gene 365057] {aka Ask1, RGD1306565}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, Atf6 (activating transcription factor 6) [NCBI Gene 304962], ATF6 (activating transcription factor 6) [NCBI Gene 22926] {aka ACHM7, ATF6A, ATP6alpha}, Stim2 (stromal interaction molecule 2) [NCBI Gene 117087], Pdia6 (protein disulfide isomerase family A, member 6) [NCBI Gene 286906] {aka CaBP1, P5, Txndc7}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, PPP1R15A (protein phosphatase 1 regulatory subunit 15A) [NCBI Gene 23645] {aka GADD34}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Gfap (glial fibrillary acidic protein) [NCBI Gene 24387], Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Traf2 (Tnf receptor-associated factor 2) [NCBI Gene 311786], Hsp90b1 (heat shock protein 90 beta family member 1) [NCBI Gene 362862] {aka Grp94, Tra1}, Ppif (peptidylprolyl isomerase F) [NCBI Gene 282819] {aka CyP-D, CypD, PPIase}, Edem1 (ER degradation enhancing alpha-mannosidase like protein 1) [NCBI Gene 297504] {aka RGD1563633}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 24516], Cybb (cytochrome b-245 beta chain) [NCBI Gene 66021] {aka Gp91-phox, Nox2}, Bak1 (BCL2-antagonist/killer 1) [NCBI Gene 116502] {aka Bak}, Ero1a (endoplasmic reticulum oxidoreductase 1 alpha) [NCBI Gene 171562] {aka Ero1l}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 314322] {aka c-fos}, Casp7 (caspase 7) [NCBI Gene 64026], Ifng (interferon gamma) [NCBI Gene 25712] {aka IFNG2, If2f}, Atp2a2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2) [NCBI Gene 29693] {aka Serca2, SercaII}, Itpr1 (inositol 1,4,5-trisphosphate receptor, type 1) [NCBI Gene 25262] {aka I145TR, IP3R1, InsP3R, InsP3R1, P400}, Hspa5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 25617] {aka BIP, GRP 78, GRP78}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Stim1 (stromal interaction molecule 1) [NCBI Gene 361618], Faslg (Fas ligand) [NCBI Gene 25385] {aka Apt1Lg1, CD95-L, Fasl, Tnfsf6, Tnlg1a}
- **Diseases:** OGD (MESH:D000860), cerebral ischemic injury (MESH:D017202), intracerebral hemorrhage (MESH:D002543), ER Stress (MESH:D000079225), ER dysfunction (MESH:D008228), ischemic tissue (MESH:D017695), MCAO (MESH:D020244), death (MESH:D003643), nervous system defects (MESH:D009421), hypertension (MESH:D006973), Alzheimer's disease (MESH:D000544), skin lesion (MESH:D012871), increased intracranial pressure (MESH:D019586), neuroinflammation (MESH:D000090862), neurological damage (MESH:D020196), neuronal (MESH:D009410), cerebral damage (MESH:D002539), Hypothermia (MESH:D007035), cardiac arrest (MESH:D006323), infarct (MESH:D007238), depression (MESH:D003866), brain infarct (MESH:D020520), Stroke (MESH:D020521), permanent (MESH:D003638), neurological diseases (MESH:D020271), nerve damage (MESH:D000080902), neurological deficits (MESH:D009461), transient cerebral ischemia (MESH:D002546), Ischemia (MESH:D007511), I/R (MESH:D015427), nausea (MESH:D009325), /R (MESH:C580424), thrombosis (MESH:D013927), apoptosis (MESH:D065703), -inflammatory (MESH:D007249), Cerebral Ischemia (MESH:D002545), hypoxic (MESH:D002534), brain edema (MESH:D001929), deficiency of ATP ion channels (OMIM:614052), Ischemic stroke (MESH:D002544), mitochondrial dysfunction (MESH:D028361), neurotoxic (MESH:D020258), common carotid artery occlusion (MESH:D002340), edema (MESH:D004487), arterial occlusion (MESH:D001157), neurobehavioral damage (MESH:D019954)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Sciuromorpha (squirrels, suborder) [taxon 33553], Adenoviridae (family) [taxon 10508], Mus sp. (mice, species) [taxon 10095], Adeno-associated virus (species) [taxon 272636], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CA1 — Homo sapiens (Human), Head and neck squamous cell carcinoma, Cancer cell line (CVCL_A5TQ), -derived Endothelial cells 3 — Mus musculus (Mouse), Transformed cell line (CVCL_0170)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8365026/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8365026/full.md

## References

174 references — full list in the complete paper: https://tomesphere.com/paper/PMC8365026/full.md

---
Source: https://tomesphere.com/paper/PMC8365026